Instem Chosen for Global Deployment of Provantis SaaS; Roche Consolidates Preclinical Software Systems

Provantis Suite to Replace Existing Solutions While Adding New Capabilities for Roche

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)-- Instem, a leading provider of early development software applications, announced today that Roche has purchased Instem’s Provantis Preclinical solution suite using its SaaS delivery model. This purchase will consolidate several key application areas and harmonize Roche sites worldwide.

Key facts

  • Roche will access the integrated General Toxicology, Pathology, Clinical Pathology and Protocol & Report Assembly (P&RA) modules using SaaS delivery model from US-based data center
  • Data Import solution being deployed allowing Roche to import data from external sources
  • Competitive evaluation conducted, Instem chosen for product coverage and SaaS capabilities
  • Roche originally using traditional on-site software from multiple suppliers; consolidation includes new automated capabilities from Instem in their Clinical Pathology Laboratories
  • Use of SaaS model to lower Roche infrastructure and support costs while enabling more frequent upgrades for access to latest features and functions
  • 4-year agreement with on-line deployment starting in 2011

“To help with the rising cost of research and development, we are again encouraged to see that organizations such as Roche are consolidating the number of IT systems and vendors, allowing them to further focus on their science,” adds Phil Reason, CEO at Instem. “Instem is well poised to support organizations such as Roche and we’ll continue to proactively work with clients as they look to meet the demand for growth while increasing efficiencies.”

“This decision will allow us to harmonize our system landscape for the non-clinical safety departments and help our scientists to further optimize laboratory processes with one fully integrated solution,” comments Alain Nanzer, Head of Non-Clinical Safety Informatics at Roche.

About Instem

Instem is a world-leading information solutions provider to the life sciences - accelerating drug and chemical development by increasing client productivity and enhancing the processes that lead to safer, more effective products. In addition to highly focused departmental and scientific solutions, Instem provides a range of business intelligence, planning, workflow management, document management and report compilation applications.

Instem supports clients around the world through full service offices in the United States, United Kingdom and China. Instem additionally has resource locations in India and a full service distributor based in Japan.

To learn more about Instem solutions and its mission, please visit www.instem.com.

Do more. Go further™.



CONTACT:

Instem
Gary Mitchell, 610-941-0990
[email protected]

KEYWORDS:   United States  North America  Pennsylvania

INDUSTRY KEYWORDS:   Technology  Data Management  Software  Health  Biotechnology  Research  Science

MEDIA:

Logo
 Logo

Suggested Articles

Moderna’s shares shrunk by nearly 5% before the long holiday weekend Thursday after a report out by Stat said the biotech was delaying its trial.

Keep your post-pandemic trials on track: learn how the right clinical supply chain partner can help sponsors avoid trial disruption. Read now>>

Helsinn Group and MEI Pharma penned a near $500 million biobucks pact for experimental blood cancer drug pracinostat back in 2016.